MTOR and non-small cell lung carcinoma: Similarly, the presence of an anaplastic lymphoma kinase (ALK) rearrangement in NSCLC is associated with high PD-L1 expression via activation of the MEK/ERK, PI3K/Akt/mTOR pathways and STAT3 [41,42,43].